Ottawa Regional Hospital & Healthcare Center
Ottawa Regional Hospital & Healthcare Center was paid $1.96M by Medicaid between Jan 2018 and Jun 2020, across 100 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 76% of everything it billed.
OTTAWA, IL 61350
Next to other Clinical Social Worker providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,370 | $551K | |
| 2019 | 40,226 | $1.09M | |
| 2020 | 13,770 | $317K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 76% | 15,819 | 2,940 | $1.49M |
| 97162 | 6.9% | 1,253 | 883 | $135K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.4% | 861 | 794 | $46K |
| 97161 | 1.6% | 280 | 199 | $31K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 3,651 | 3,323 | $22K |
| 80053 | Comprehensive metabolic panel | 1.1% | 6,837 | 5,687 | $22K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.0% | 699 | 600 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 908 | 796 | $15K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 910 | 797 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,533 | 1,375 | $14K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 369 | 91 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 169 | 113 | $11K |
88 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,140 | $10K |
| 73610 | <1% | 512 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,200 | $8K |
| 73110 | <1% | 550 | $7K | |
| 87081 | <1% | 2,388 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 335 | $6K |
| 73564 | <1% | 472 | $6K | |
| 73630 | <1% | 462 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 561 | $5K |
| 73030 | <1% | 356 | $4K | |
| 80061 | Lipid panel | <1% | 2,898 | $4K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 433 | $4K |
| 73130 | <1% | 378 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 386 | $3K |
| 82607 | <1% | 870 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 998 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,885 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,282 | $3K |
| 87186 | <1% | 548 | $3K | |
| 84439 | <1% | 1,178 | $2K | |
| 97163 | <1% | 20 | $2K | |
| 86780 | <1% | 448 | $2K | |
| 85610 | <1% | 975 | $1K | |
| 83735 | <1% | 949 | $1K | |
| 84466 | <1% | 557 | $1K | |
| 85027 | <1% | 805 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 168 | $1K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 13 | $1K |
| 87510 | <1% | 182 | $1K | |
| 83655 | <1% | 211 | $1K | |
| 82728 | <1% | 564 | $1K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 13 | $1K |
| 82570 | <1% | 822 | $994.09 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 46 | $969.91 |
| 87480 | <1% | 183 | $936.83 | |
| 72100 | <1% | 76 | $893.39 | |
| 81001 | <1% | 1,243 | $884.90 | |
| 73502 | <1% | 58 | $865.77 | |
| 86803 | <1% | 188 | $856.06 | |
| 82746 | <1% | 297 | $838.28 | |
| 83540 | <1% | 572 | $825.14 | |
| 73080 | <1% | 71 | $745.69 | |
| 87340 | <1% | 214 | $722.70 | |
| 87147 | <1% | 429 | $711.72 | |
| 86140 | <1% | 550 | $620.91 | |
| 82043 | <1% | 684 | $620.20 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 33 | $585.55 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $529.57 |
| 84481 | <1% | 270 | $525.26 | |
| Q3014 | Telehealth originating site facility fee | <1% | 22 | $514.28 |
| 84702 | <1% | 142 | $477.43 | |
| 87660 | <1% | 184 | $475.04 | |
| 84403 | <1% | 38 | $411.80 | |
| 86038 | <1% | 79 | $370.81 | |
| 86850 | <1% | 227 | $368.11 | |
| 87522 | Neg quan hep c or qual rna | <1% | 14 | $358.84 |
| 85652 | <1% | 619 | $358.75 | |
| 81003 | <1% | 543 | $298.20 | |
| 87400 | <1% | 68 | $284.73 | |
| 86003 | <1% | 14 | $267.47 | |
| 74018 | <1% | 28 | $232.75 | |
| 80069 | <1% | 86 | $203.66 | |
| 81025 | <1% | 278 | $202.40 | |
| 88720 | <1% | 88 | $181.88 | |
| 83970 | <1% | 14 | $170.19 | |
| 86901 | <1% | 167 | $167.19 | |
| 73562 | <1% | 17 | $157.27 | |
| 97166 | <1% | 14 | $150.23 | |
| 87070 | <1% | 62 | $140.28 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 97 | $135.99 |
| 80074 | <1% | 28 | $131.09 | |
| 82950 | <1% | 97 | $123.34 | |
| 84550 | <1% | 152 | $118.60 | |
| 86900 | <1% | 168 | $114.09 | |
| 73140 | <1% | 15 | $99.49 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $95.50 |
| 83690 | <1% | 85 | $88.29 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 33 | $78.58 |
| 83721 | <1% | 13 | $72.70 | |
| 82784 | <1% | 17 | $58.71 | |
| 86431 | <1% | 42 | $42.24 | |
| 82785 | <1% | 15 | $31.50 | |
| 86762 | <1% | 20 | $27.93 | |
| 85018 | <1% | 41 | $22.69 | |
| 87088 | <1% | 12 | $16.50 | |
| 82550 | <1% | 15 | $14.80 | |
| 86308 | <1% | 12 | $14.15 | |
| 83516 | <1% | 12 | $12.82 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Osf Healthcare System | Peoria, IL | $16.78M |
| ST Francis Hospital | Escanaba, MI | $14.37M |
| Saint Francis Medical Center | Peoria, IL | $11.26M |
| ST Francis Hospital | Escanaba, MI | $7.92M |
| Saint Francis Medical Center | Peoria, IL | $7.30M |
| Saint Anthony Medical Center | Loves Park, IL | $6.62M |
| ST Mary Medical Center | Galesburg, IL | $5.10M |
| Osf Healthcare System | Monmouth, IL | $4.94M |
| ST Joseph Medical Center | Bloomington, IL | $4.76M |
| Saint Anthony Medical Center | Rockford, IL | $1.95M |
| ST Joseph Medical Center | Bloomington, IL | $1.94M |
| Osf Healthcare System | Rockford, IL | $1.45M |
| Osf Healthcare System | Monmouth, IL | $1.12M |
| ST Francis Hospital | Gladstone, MI | $969K |
| ST Mary Medical Center | Galesburg, IL | $931K |
| Saint James Hospital | Pontiac, IL | $688K |
| Saint Anthony Medical Center | Rockford, IL | $420K |
| Saint Francis Medical Center | Peoria, IL | $374K |
| Osf Healthcare System | Oak Lawn, IL | $368K |
| Mendota Community Hospital | Mendota, IL | $359K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.